Drug Shortage Report for UROCIT-K
| Report ID | 174714 |
| Drug Identification Number | 01914022 |
| Brand name | UROCIT-K |
| Common or Proper name | Potassium Citrate Extended Release Tablets |
| Company Name | MISSION PHARMACAL COMPANY |
| Market Status | MARKETED |
| Active Ingredient(s) | POTASSIUM CITRATE |
| Strength(s) | 540MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100-ct |
| ATC code | A12BA |
| ATC description | POTASSIUM |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2022-11-15 |
| Actual start date | |
| Estimated end date | 2022-12-05 |
| Actual end date | 2022-12-05 |
| Shortage status | Resolved |
| Updated date | 2023-10-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 10999 IH 10 WEST SAN ANTONIO, TEXAS UNITED STATES 78230-1355 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2023-10-03 | French | Compare |
| v6 | 2023-10-03 | English | Compare |
| v5 | 2022-11-29 | French | Compare |
| v4 | 2022-11-29 | English | Compare |
| v3 | 2022-11-16 | English | Compare |
| v2 | 2022-11-15 | French | Compare |
| v1 | 2022-11-15 | English | Compare |
Showing 1 to 7 of 7